Ali Mohammad Alizadeh

12PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 27, 2025
Predicting fibroblast activation protein overexpression in the overall survival rate of cancer patients: a systematic review and meta-analysis.

Majid Janani, Amirhoushang Poorkhani, Mirmohammadhosseinaali Sharifiandavaei

|Sep 19, 2023
Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.

Farhad Zamani, Solmaz Khalighfard, Mohammad Reza Kalhori

|Jan 07, 2023
Breast tumor metastasis following filgrastim administration due to the SDF-1/CXCR4 pathway.

Solmaz Khalighfard, Vahid Khori, Ebrahim Esmati

|Dec 13, 2021
The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA?

Mohammad Reza Kalhori, Masoud Soleimani, Ehsan Arefian

|Feb 05, 2020
Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells.

Meysam Soleymani, Solmaz Khalighfard, Saeed Khodayari

|Dec 21, 2018
Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.

Solmaz Khalighfard, Ali Mohammad Alizadeh, Shiva Irani

Pageof 2

Frequent Collaborators

2 joint publications

Mohammad Reza Kalhori

1 joint publications

Amin Isanejad

1 joint publications

Meysam Soleymani

1 joint publications

Mahmoud Reza Hadjighassem